{"gao_id": "GAO-21-151", "published": "2020-12-17T12:00:00Z", "released": "2021-01-19T07:00:00Z", "summary": "Agencies' regulatory analyses can help policymakers determine whether the benefits of regulation or deregulation are likely to justify the costs. We reviewed agency analyses of 11 EPA and Health and Human Services regulations. When looking at the costs and benefits that agencies translated into dollar values, analyses for 8 of the regulations showed costs exceeding benefits. Reviewing those more closely, we found that some analyses...", "title": "Federal Rulemaking: Selected EPA and HHS Regulatory Analyses Met Several Best Practices, but CMS Should Take Steps to Strengthen Its Analyses", "topics": ["Economic effects", "Cost analysis", "Medicare", "Cost control", "Regulatory analysis", "Agency evaluation", "Compliance oversight", "Benefit-cost tracking", "Program transparency", "Environmental protection", "Reporting requirements", "Federal spending transparency", "Performance measurement", "Executive orders", "Quality improvement", "Economic analysis", "Government Operations", "Cost savings", "Cost effectiveness analysis", "Best practices"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-21-151", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-21-151-highlights.pdf"}, {"title": "Full Report (51 pages)", "url": "https://www.gao.gov/assets/gao-21-151.pdf"}, {"title": "Accessible PDF (58 pages)", "url": "https://www.gao.gov/assets/720/711574.pdf"}]}